EDX Medical Group

Cambridge, United Kingdom Founded: 2022 • Age: 4 yrs
Medical diagnostics solutions are researched by the laboratory.
Annual revenue - Latest available
Total funding $2.1M 1 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About EDX Medical Group

EDX Medical Group is a company based in Cambridge (United Kingdom) founded in 2022 by Chris Evans. EDX Medical Group has raised $2.15 million across 1 funding round from investors including Bridgemere, Robert Marshall and Paul Thandi CBE DL. EDX Medical Group has completed 2 acquisitions, including Hutano Diagnostics and Torax Biosciences. EDX Medical Group operates in a competitive market with competitors including EKF, LumiraDx, SpinChip, LightDeck Diagnostics and ProciseDx, among others.

  • Headquarter Cambridge, United Kingdom
  • Founders Chris Evans
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Edx Medical Group Plc
  • Date of Incorporation 19 Mar, 2021
  • Jurisdiction CAMBRIDGE, CAMBS, ENGLAND
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $2.15 M (USD)

    in 1 rounds

  • Latest Funding Round
    $2.15 M (USD), Seed

    Apr 26, 2023

  • Investors
    Bridgemere

    & 2 more

  • Employee Count
    Not available
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of EDX Medical Group

EDX Medical Group has successfully raised a total of $2.15M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.15 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in EDX Medical Group

EDX Medical Group has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Bridgemere, Robert Marshall and Paul Thandi CBE DL.

All
Institutional
Angel
Investor Description Founded Year Domain Location
Parent company for housebuilding, land development, leisure, and long-term investments.
Locked Locked Locked

Robert Marshall

Indian angel investor with focus on early-stage tech startups.
Locked Locked Locked

Paul Thandi CBE DL

-
Locked Locked Locked
Premium access

Investor details for EDX Medical Group

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by EDX Medical Group

EDX Medical Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Hutano Diagnostics and Torax Biosciences.

Investments
Premium access

Investment portfolio details for EDX Medical Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Diagnostic tools for early disease detection and management are developed.
Locked Locked 2018 Locked
IVD reagents and instruments for diagnostic testing are developed.
Locked Locked 2017 Locked
Premium access

Complete acquisition details for EDX Medical Group

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - EDX Medical Group

Premium access

Detailed financials for EDX Medical Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Edx Medical Group Comparisons

EDX Medical Group Primary company
Description
Medical diagnostics solutions are researched by the laborato...
Location
Cambridge, United Kingdom
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for EDX Medical Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of EDX Medical Group

EDX Medical Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, LumiraDx, SpinChip, LightDeck Diagnostics and ProciseDx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Point-of-care and laboratory blood analyzers are developed by EKF.
Locked Locked Locked
Cloud based diagnostics platform for point of care diagnosing
Locked Locked Locked
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
Locked Locked Locked
Point-of-care diagnostic devices for multiplex assays are developed.
Locked Locked Locked
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
Premium access

Detailed competitors of EDX Medical Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Edx Medical Group

Premium access

Complete news archive for EDX Medical Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EDX Medical Group

EDX Medical Group was founded in 2022 and raised its 1st funding round 1 year after it was founded.

EDX Medical Group is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Mike Hudson is the current CEO of EDX Medical Group.

EDX Medical Group is a funded company, having raised a total of $2.15M across 1 funding round to date.

EDX Medical Group was founded in 2022 and is located in Cambridge, United Kingdom. Operations center on research within the medical diagnostics sector. Solutions for healthcare diagnostics are developed through laboratory-based activities. The company is led by Founder Chris Evans and CEO Mike Hudson. Focus remains on advancing diagnostic technologies in the UK healthcare landscape.

EDX Medical Group's top competitors include EKF, LumiraDx and SpinChip.

EDX Medical Group has made 2 acquisitions, including Hutano Diagnostics, and Torax Biosciences.

EDX Medical Group has 3 investors. Key investors include Bridgemere, Robert Marshall, and Paul Thandi CBE DL.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available